Exact Mass: 439.124

Exact Mass Matches: 439.124

Found 54 metabolites which its exact mass value is equals to given mass value 439.124, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

N-(3-Phenylpropyl)-3,4-dihydroxybenzylidene cyanoacetamide

2,2,4,4-tetracyano-N-{[3,4-dihydroxy-2-(3-phenylpropyl)phenyl]methylidene}-3-oxobutanamide

C24H17N5O4 (439.128)


D000970 - Antineoplastic Agents > D020032 - Tyrphostins

   
   

N12-5(S)-N13-1(R)-L-digitoxosylarcyriaflavin A

N12-5(S)-N13-1(R)-L-digitoxosylarcyriaflavin A

C25H17N3O5 (439.1168)


   

3-Methoxy-dictamnine-4-(2,3,4-trimethoxy)-benzoic acid

"NCGC00160277-01!3-Methoxy-dictamnine-4-(2,3,4-trimethoxy)-benzoic acid"

C23H21NO8 (439.1267)


   

Cys Cys Asn Thr

(2S,3R)-2-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-hydroxybutanoic acid

C14H25N5O7S2 (439.1195)


   

Cys Cys Gln Ser

(2S)-2-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-4-carbamoylbutanamido]-3-hydroxypropanoic acid

C14H25N5O7S2 (439.1195)


   

Cys Cys Ser Gln

(2S)-2-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-hydroxypropanamido]-4-carbamoylbutanoic acid

C14H25N5O7S2 (439.1195)


   

Cys Cys Thr Asn

(2S)-2-[(2S,3R)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-hydroxybutanamido]-3-carbamoylpropanoic acid

C14H25N5O7S2 (439.1195)


   

Cys Asn Cys Thr

(2S,3R)-2-[(2R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-hydroxybutanoic acid

C14H25N5O7S2 (439.1195)


   

Cys Asn Thr Cys

(2R)-2-[(2S,3R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-hydroxybutanamido]-3-sulfanylpropanoic acid

C14H25N5O7S2 (439.1195)


   

Cys Gln Cys Ser

(2S)-2-[(2R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-carbamoylbutanamido]-3-sulfanylpropanamido]-3-hydroxypropanoic acid

C14H25N5O7S2 (439.1195)


   

Cys Gln Ser Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-carbamoylbutanamido]-3-hydroxypropanamido]-3-sulfanylpropanoic acid

C14H25N5O7S2 (439.1195)


   

Cys Ser Cys Gln

(2S)-2-[(2R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxypropanamido]-3-sulfanylpropanamido]-4-carbamoylbutanoic acid

C14H25N5O7S2 (439.1195)


   

Cys Ser Gln Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxypropanamido]-4-carbamoylbutanamido]-3-sulfanylpropanoic acid

C14H25N5O7S2 (439.1195)


   

Cys Thr Cys Asn

(2S)-2-[(2R)-2-[(2S,3R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxybutanamido]-3-sulfanylpropanamido]-3-carbamoylpropanoic acid

C14H25N5O7S2 (439.1195)


   

Cys Thr Asn Cys

(2R)-2-[(2S)-2-[(2S,3R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxybutanamido]-3-carbamoylpropanamido]-3-sulfanylpropanoic acid

C14H25N5O7S2 (439.1195)


   

Asn Cys Cys Thr

(2S,3R)-2-[(2R)-2-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-hydroxybutanoic acid

C14H25N5O7S2 (439.1195)


   

Asn Cys Thr Cys

(2R)-2-[(2S,3R)-2-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-hydroxybutanamido]-3-sulfanylpropanoic acid

C14H25N5O7S2 (439.1195)


   

Asn Thr Cys Cys

(2R)-2-[(2R)-2-[(2S,3R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxybutanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C14H25N5O7S2 (439.1195)


   

Gln Cys Cys Ser

(2S)-2-[(2R)-2-[(2R)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-hydroxypropanoic acid

C14H25N5O7S2 (439.1195)


   

Gln Cys Ser Cys

(2R)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-sulfanylpropanamido]-3-hydroxypropanamido]-3-sulfanylpropanoic acid

C14H25N5O7S2 (439.1195)


   

Gln Ser Cys Cys

(2R)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-hydroxypropanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C14H25N5O7S2 (439.1195)


   

Ser Cys Cys Gln

(2S)-2-[(2R)-2-[(2R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]-4-carbamoylbutanoic acid

C14H25N5O7S2 (439.1195)


   

Ser Cys Gln Cys

(2R)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-sulfanylpropanamido]-4-carbamoylbutanamido]-3-sulfanylpropanoic acid

C14H25N5O7S2 (439.1195)


   

Ser Gln Cys Cys

(2R)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-carbamoylbutanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C14H25N5O7S2 (439.1195)


   

Thr Cys Cys Asn

(2S)-2-[(2R)-2-[(2R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-carbamoylpropanoic acid

C14H25N5O7S2 (439.1195)


   

Thr Cys Asn Cys

(2R)-2-[(2S)-2-[(2R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-sulfanylpropanoic acid

C14H25N5O7S2 (439.1195)


   

Thr Asn Cys Cys

(2R)-2-[(2R)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C14H25N5O7S2 (439.1195)


   
   

2-[[2-[(2-formamido-4-methylsulfanylbutanoyl)amino]-4-methylsulfanylbutanoyl]amino]-4-methylsulfanylbutanoic acid

2-[[2-[(2-formamido-4-methylsulfanylbutanoyl)amino]-4-methylsulfanylbutanoyl]amino]-4-methylsulfanylbutanoic acid

C16H29N3O5S3 (439.1269)


   

8-Azabicyclo(3.2.1)octan-3-ol, 8-(bis(2-chlorophenyl)methyl)-3-(2-pyrimidinyl)-

8-Azabicyclo(3.2.1)octan-3-ol, 8-(bis(2-chlorophenyl)methyl)-3-(2-pyrimidinyl)-

C24H23Cl2N3O (439.1218)


   

Amibegron hydrochloride

Amibegron hydrochloride

C22H27Cl2NO4 (439.1317)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists Amibegron hydrochloride is a selective β3-adrenoceptor agonist, with an EC50 of 3.5 nM for β-adrenoceptor in rat colon; Amibegron hydrochloride has anxiolytic and antidepressant activity.

   

N-cyclohexyl-1-(2,4-dichlorophenyl)-6-methyl-4H-indeno[1,2-c]pyrazole-3-carboxamide

N-cyclohexyl-1-(2,4-dichlorophenyl)-6-methyl-4H-indeno[1,2-c]pyrazole-3-carboxamide

C24H23Cl2N3O (439.1218)


   

Folate(2-)

Folate(2-)

C19H17N7O6-2 (439.124)


COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

(Z)-1-(glutathione-S-yl)-2-phenylacetohydroximate

(Z)-1-(glutathione-S-yl)-2-phenylacetohydroximate

C18H23N4O7S- (439.1287)


   

(gamma-glutamylcysteine-S-yl)-bimane

(gamma-glutamylcysteine-S-yl)-bimane

C18H23N4O7S- (439.1287)


   
   

6a,7-Didehydro-1,9,10-trihydroxy-2-methoxy-6-methylaporphinium trifluoroacetate

6a,7-Didehydro-1,9,10-trihydroxy-2-methoxy-6-methylaporphinium trifluoroacetate

C21H20F3NO6 (439.1243)


A natural product found in Gnetum montanum.

   

2-(4-chlorophenoxy)-N-[4-[4-[2-furanyl(oxo)methyl]-1-piperazinyl]phenyl]acetamide

2-(4-chlorophenoxy)-N-[4-[4-[2-furanyl(oxo)methyl]-1-piperazinyl]phenyl]acetamide

C23H22ClN3O4 (439.1299)


   

2-(1-Benzimidazolyl)acetic acid [2-[(9,10-dioxo-1-anthracenyl)amino]-2-oxoethyl] ester

2-(1-Benzimidazolyl)acetic acid [2-[(9,10-dioxo-1-anthracenyl)amino]-2-oxoethyl] ester

C25H17N3O5 (439.1168)


   

N-[4-[cyano-[3-(3-hydroxypropylamino)-2-quinoxalinyl]methyl]sulfonylphenyl]acetamide

N-[4-[cyano-[3-(3-hydroxypropylamino)-2-quinoxalinyl]methyl]sulfonylphenyl]acetamide

C21H21N5O4S (439.1314)


   

[2-(4-amino-1,3-dimethyl-2,6-dioxopyrimidin-5-yl)-2-oxoethyl] (E)-3-[4-(difluoromethoxy)-3-methoxyphenyl]prop-2-enoate

[2-(4-amino-1,3-dimethyl-2,6-dioxopyrimidin-5-yl)-2-oxoethyl] (E)-3-[4-(difluoromethoxy)-3-methoxyphenyl]prop-2-enoate

C19H19F2N3O7 (439.1191)


   

2-azaniumyl-5-[[3-[(Z)-C-benzyl-N-hydroxycarbonimidoyl]sulfanyl-1-(carboxylatomethylamino)-1-oxopropan-2-yl]amino]-5-oxopentanoate

2-azaniumyl-5-[[3-[(Z)-C-benzyl-N-hydroxycarbonimidoyl]sulfanyl-1-(carboxylatomethylamino)-1-oxopropan-2-yl]amino]-5-oxopentanoate

C18H23N4O7S- (439.1287)


   

N-[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-thiophenesulfonamide

N-[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-thiophenesulfonamide

C19H25N3O5S2 (439.1236)


   

N-[2-(3,4-dimethoxyphenyl)ethyl]-3-[4-methoxy-3-(sulfooxy)phenyl]propanimidic acid

N-[2-(3,4-dimethoxyphenyl)ethyl]-3-[4-methoxy-3-(sulfooxy)phenyl]propanimidic acid

C20H25NO8S (439.1301)


   

[4-[2-[3-(3,4-Dimethoxyphenyl)propanoylamino]ethyl]-2-methoxyphenyl] hydrogen sulate

[4-[2-[3-(3,4-Dimethoxyphenyl)propanoylamino]ethyl]-2-methoxyphenyl] hydrogen sulate

C20H25NO8S (439.1301)


   

sulfo 1-cyclopropyl-6-fluoro-5-methyl-7-[(3S)-3-methylpiperazin-1-yl]-4-oxoquinoline-3-carboxylate

sulfo 1-cyclopropyl-6-fluoro-5-methyl-7-[(3S)-3-methylpiperazin-1-yl]-4-oxoquinoline-3-carboxylate

C19H22FN3O6S (439.1213)


   

1-cyclopropyl-6-fluoro-5-methyl-7-[(3S)-3-methyl-4-sulfopiperazin-1-yl]-4-oxoquinoline-3-carboxylic acid

1-cyclopropyl-6-fluoro-5-methyl-7-[(3S)-3-methyl-4-sulfopiperazin-1-yl]-4-oxoquinoline-3-carboxylic acid

C19H22FN3O6S (439.1213)


   

4,8-Dimethoxyfuro[2,3-b]quinolin-7-yl 3,4,5-trimethoxybenzoate

4,8-Dimethoxyfuro[2,3-b]quinolin-7-yl 3,4,5-trimethoxybenzoate

C23H21NO8 (439.1267)


   

Folate(2-)

Folate(2-)

C19H17N7O6 (439.124)


The dicarboxylic acid dianion formed from folic acid by loss of a proton from each of the two carboxy groups in the glutamic acid moiety.

   
   

methyl 4-[hydroxy(methoxy)methyl]furan-2-carboxylate; utahmycin a

methyl 4-[hydroxy(methoxy)methyl]furan-2-carboxylate; utahmycin a

C23H21NO8 (439.1267)


   

methyl (1r,3r,4r,5r,7r,9r,11s,12s,13s)-5-(6-aminopurin-9-yl)-1,4,12,13-tetrahydroxy-2,6,10-trioxatricyclo[7.4.0.0³,⁷]tridecane-11-carboxylate

methyl (1r,3r,4r,5r,7r,9r,11s,12s,13s)-5-(6-aminopurin-9-yl)-1,4,12,13-tetrahydroxy-2,6,10-trioxatricyclo[7.4.0.0³,⁷]tridecane-11-carboxylate

C17H21N5O9 (439.1339)


   

methyl (1r,3s,4s,5r,7r,9r,11s,12s,13s)-5-(6-aminopurin-9-yl)-1,4,12,13-tetrahydroxy-2,6,10-trioxatricyclo[7.4.0.0³,⁷]tridecane-11-carboxylate

methyl (1r,3s,4s,5r,7r,9r,11s,12s,13s)-5-(6-aminopurin-9-yl)-1,4,12,13-tetrahydroxy-2,6,10-trioxatricyclo[7.4.0.0³,⁷]tridecane-11-carboxylate

C17H21N5O9 (439.1339)